Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P09972
UPID:
ALDOC_HUMAN
Alternative names:
Brain-type aldolase
Alternative UPACC:
P09972; B2R5R3; Q3SYL3; Q6FH94; Q6P0L5
Background:
Fructose-bisphosphate aldolase C, also known as Brain-type aldolase, plays a crucial role in glycolysis and gluconeogenesis, metabolic pathways essential for energy production and glucose synthesis, respectively. Its presence in the brain suggests a specialized function in neuronal energy metabolism.
Therapeutic significance:
Understanding the role of Fructose-bisphosphate aldolase C could open doors to potential therapeutic strategies. Its critical function in energy metabolism makes it a potential target for addressing metabolic disorders and enhancing brain health.